J9298 Injection nivol relatlimab 3mg/1mg
Also known as: nivolumab relatlimab, Opdualag
Injection of nivolumab combined with relatlimab, 3 milligram and 1 milligram respectively. Dual checkpoint inhibitor combination therapy.
In Plain Language
immunotherapy combination injection; dual checkpoint therapy
Clinical Context
First-line therapy for metastatic melanoma. Combines PD-1 and lymphocyte activation gene-3 (LAG-3) inhibition for enhanced immune response.
RVU Information
CPT J9298 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9298?
CPT J9298 (Injection nivol relatlimab 3mg/1mg) is a J Codes (Drugs) code. Injection of nivolumab combined with relatlimab, 3 milligram and 1 milligram respectively. Dual checkpoint inhibitor combination therapy.
How is J9298 administered?
CPT J9298 is administered by a healthcare provider, typically via injection or infusion. First-line therapy for metastatic melanoma. Combines PD-1 and lymphocyte activation gene-3 (LAG-3) inhibition for enhanced immune response. It is used by Oncology, Dermatology, Immunology.
When is CPT J9298 used?
First-line therapy for metastatic melanoma. Combines PD-1 and lymphocyte activation gene-3 (LAG-3) inhibition for enhanced immune response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.